HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Tokgoz, B. Search for Related Content PubMed PubMed Citation Articles by Tokgoz, B.

CLINICAL ADVANTAGES OF PERITONEAL DIALYSIS

Erciyes University School of Medicine, Department of Nephrology, Kayseri, Turkey

Correspondence to: B. Tokgoz, Erciyes Universitesi, Tip Fakultesi, Nefroloji Bilim Dali, 38039 Kayseri, Turkey. bulentto{at}gmail.com

Chronic peritoneal dialysis (PD) continues to be an option in the treatment of end-stage renal disease (ESRD). Medical, social, and logistic considerations are needed to determine the most suitable dialysis option for an ESRD patient. Peritoneal dialysis has been advancing in terms of technique, new exchange systems, and a new generation of solutions. A survival advantage for PD patients has been noted over the first 1 – 2 years after the onset of the dialysis. Most patients may need both dialytic modalities in time, and therefore the sequence of the treatment options is important. Compared with hemodialysis patients, PD patients seem much more satisfied in most of the studies that evaluate quality of life during treatment. A preference for PD may be more advantageous in the pre-transplantation period. Moreover, much lower doses of erythropoietin have been shown to be sufficient for PD patients. Also, PD has been reported to protect residual renal functions better in many studies.

KEY WORDS: Survival; residual renal function.

Copyright © 2009 by Multimed Inc.